News

CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...

Home December 04, 2006
Home
News

The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...

Home December 04, 2006
Home
News

Recent downplay of the media’s attention to DES-related thrombosis during both the TCT and AHA conferences this fall may ...

Home December 04, 2006
Home
Case Study

One of the major dilemmas faced by clinicians in the Intensive Care Unit (ICU) is the determination of volume status and ...

Home December 04, 2006
Home
News

Toronto-based Cedara Software, a Merge Healthcare company and an independent developer of medical software technologies ...

Home December 04, 2006
Home
Feature | Judy Harvey

Pulse oximetry, which directly monitors the patient's oxygenation, came into its own as standard medical practice 20 ...

Home December 04, 2006
Home
News

Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”

Home December 03, 2006
Home
News

Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.

Home December 03, 2006
Home
News

Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...

Home December 03, 2006
Home
News

AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) ...

Home December 03, 2006
Home
News

An implantable technology to control high blood pressure in patients not responding to available medicines has ...

Home November 29, 2006
Home
News

GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image ...

Home November 29, 2006
Home
News

The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during ...

Home November 29, 2006
Home
News

The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.

Home November 29, 2006
Home
News

An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available ...

Home November 29, 2006
Home
Subscribe Now